Compare PGIM India Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹1000
₹500
Expense Ratio
2.37
1.93
NAV
₹10.07
₹429.14
Fund Started
19 Nov 2024
04 Jun 1999
Fund Size
₹92.45 Cr
₹4076.67 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
13.27%
9.15%
3 Year
-
26.00%
5 Year
-
17.02%
Equity
97.80%
98.53%
Cash
0.02%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.31% |
Divi's Laboratories Ltd. | 10.32% |
Dr. Reddy's Laboratories Ltd. | 6.36% |
Aster DM Healthcare Ltd. | 6.24% |
JB Chemicals & Pharmaceuticals Ltd. | 6.09% |
Max Healthcare Institute Ltd. | 5.33% |
Rubicon Research Ltd. | 5.00% |
Mankind Pharma Ltd. | 4.95% |
Ajanta Pharma Ltd. | 4.80% |
Abbott India Ltd. | 3.74% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
19 Nov 2024
04 Jun 1999
